NCT00739466 - Biorest Liposomal Alendronate With Stenting sTudy (BLAST) | Biotech Hunter

Enrollment

226

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

Coronary Artery Stenosis

Interventions

DRUG

Liposomal Alendronate

IV in a single low dose during the index procedure (coronary stent implantation) over 2 hours

DRUG

Liposomal Alendronate

IV in a single high dose during the index procedure (coronary stent implantation) over 2 hours

DRUG

Saline infusion (placebo)

IV saline infusion during the index procedure (coronary stent implantation) over 2 hours

Trial Locations (12)

The Baruch Padeh Medical Center, Poriya, Poria – Neve Oved

Western Galilee Hospital, Nahariya, Nahariya

Bnei Zion Medical Center, Haifa

Rambam Health Care Campus, Haifa

Lady Davis Carmel Medical Center, Haifa

Hillel Yaffe Medical Center, Hadera

Meir Medical Center, Kfar Saba

Rabin Medical Center, Petah Tikva

Sheba Medical Center, Tel Hashomer, Ramat Gan

The Tel Aviv Sourasky Medical Center, Tel Aviv

Kaplan Medical Center, Rehovot

Shaare Zedek Medical Center, Jerusalem